Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 1;9(10):e002955. doi: 10.1136/jitc-2021-002955

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Outcomes for patients with advanced melanoma treated with anti-PD-1 therapy. Of 122, 24 (20%) of patients came off treatment by choice based on no evidence of active disease by imaging and/or biopsy. Of 122, 28 (23%) of patients came off treatment due to toxicity with disease control. CTLA-4, cytotoxic T-lymphocyte-associated protein 4; NSCLC, non-small-cell lung cancer; PD-1, programmed cell death protein 1; TVEC, talimogene laherparepvec; CRC, colorectal cancer; PR, partial response.